David E.  Shaw net worth and biography

David Shaw Biography and Net Worth

Major Shareholder of Schrödinger

David Shaw is the founder of D. E. Shaw & Co., a hedge fund described by Fortune as "the most intriguing and mysterious force on Wall Street." Additionally, he is the chief scientist for D.E. Shaw Research, which is engaged in scientific research and technological development in the field of computational biochemistry.

Shaw worked as a vice president for Morgan Stanley, as well as serving on Columbia University’s computer science faculty until 1986, when he set out on his own to pursue computational finance. He founded D.E. Shaw & Co. in 1988 and was dubbed “King Quant” by Fortune in 1996 because of the firm's pioneering role in high-speed quantitative trading.

Shaw initiated his work on computational biochemistry, specifically molecular dynamics simulations of proteins, in 2001, and he began building his scientific team at D. E. Shaw Research in 2002. A few years later in 2005, he reinitiated his affiliation with Columbia. He currently serves as a senior research fellow and an adjunct professor of biochemistry and molecular biophysics. 

In 1994, Shaw was appointed to the President’s Council of Advisors on Science and Technology by President Clinton, and in 2009, he joined the council again under President Obama. Additionally, in 2012, he was elected to the National Academy of Engineering. He is a fellow of the American Academy of Arts and Sciences and a recipient of the ACM Gordon Bell Prize.

Shaw holds a bachelor’s degree from the University of California, San Diego and a Ph.D. from Stanford University. 

What is David E. Shaw's net worth?

The estimated net worth of David E. Shaw is at least $230.65 million as of November 23rd, 2020. Mr. Shaw owns 8,981,664 shares of Schrödinger stock worth more than $230,649,132 as of March 19th. This net worth approximation does not reflect any other investments that Mr. Shaw may own. Learn More about David E. Shaw's net worth.

How do I contact David E. Shaw?

The corporate mailing address for Mr. Shaw and other Schrödinger executives is 120 WEST 45TH STREET 17TH FLOOR, NEW YORK NY, 10036. Schrödinger can also be reached via phone at 212-295-5800 and via email at [email protected]. Learn More on David E. Shaw's contact information.

Has David E. Shaw been buying or selling shares of Schrödinger?

David E. Shaw has not been actively trading shares of Schrödinger over the course of the past ninety days. Most recently, David E. Shaw sold 63,061 shares of the business's stock in a transaction on Monday, July 19th. The shares were sold at an average price of $68.07, for a transaction totalling $4,292,562.27. Learn More on David E. Shaw's trading history.

Who are Schrödinger's active insiders?

Schrödinger's insider roster includes Robert Abel (Insider), Karen Akinsanya (Insider), Rosana Kapeller-Libermann (Director), Joel Lebowitz (CFO), David Shaw (Major Shareholder), Yvonne Tran (EVP), and Jorg Weiser (Director). Learn More on Schrödinger's active insiders.

Are insiders buying or selling shares of Schrödinger?

During the last twelve months, insiders at the sold shares 8 times. They sold a total of 48,501 shares worth more than $1,943,224.69. The most recent insider tranaction occured on February, 12th when EVP Yvonne Tran sold 758 shares worth more than $21,443.82. Insiders at Schrödinger own 7.6% of the company. Learn More about insider trades at Schrödinger.

Information on this page was last updated on 2/12/2024.

David E. Shaw Insider Trading History at Schrödinger

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/19/2021Sell63,061$68.07$4,292,562.27View SEC Filing Icon  
7/16/2021Sell29,000$67.05$1,944,450.00View SEC Filing Icon  
7/14/2021Sell34,051$68.05$2,317,170.55View SEC Filing Icon  
7/12/2021Sell20,930$74.33$1,555,726.90View SEC Filing Icon  
7/8/2021Sell48,410$74.40$3,601,704.00View SEC Filing Icon  
7/6/2021Sell25,230$75.29$1,899,566.70View SEC Filing Icon  
7/1/2021Sell41,575$76.22$3,168,846.50View SEC Filing Icon  
6/25/2021Sell220,394$77.99$17,188,528.06View SEC Filing Icon  
6/23/2021Sell53,946$77.00$4,153,842.00View SEC Filing Icon  
6/21/2021Sell60,449$74.86$4,525,212.14View SEC Filing Icon  
6/18/2021Sell52,784$74.47$3,930,824.48View SEC Filing Icon  
6/16/2021Sell37,195$74.36$2,765,820.20View SEC Filing Icon  
6/14/2021Sell43,463$77.51$3,368,817.13View SEC Filing Icon  
5/26/2021Sell980$68.93$67,551.40View SEC Filing Icon  
5/24/2021Sell27,594$65.47$1,806,579.18View SEC Filing Icon  
5/20/2021Sell25,000$64.23$1,605,750.00View SEC Filing Icon  
5/18/2021Sell28,402$63.96$1,816,591.92View SEC Filing Icon  
5/14/2021Sell25,000$60.31$1,507,750.00View SEC Filing Icon  
5/12/2021Sell25,000$60.33$1,508,250.00View SEC Filing Icon  
5/6/2021Sell30,000$66.96$2,008,800.00View SEC Filing Icon  
5/4/2021Sell30,000$69.79$2,093,700.00View SEC Filing Icon  
4/29/2021Sell101,525$76.58$7,774,784.50
4/21/2021Sell30,000$71.71$2,151,300.00View SEC Filing Icon  
4/19/2021Sell30,000$74.13$2,223,900.00View SEC Filing Icon  
4/15/2021Sell45,000$78.27$3,522,150.00View SEC Filing Icon  
4/13/2021Sell40,400$74.89$3,025,556.00View SEC Filing Icon  
4/9/2021Sell35,000$74.00$2,590,000.00View SEC Filing Icon  
4/7/2021Sell35,600$76.00$2,705,600.00View SEC Filing Icon  
4/1/2021Sell184,043$76.12$14,009,353.16
3/24/2021Sell50,000$68.68$3,434,000.00View SEC Filing Icon  
3/22/2021Sell50,000$81.36$4,068,000.00View SEC Filing Icon  
3/18/2021Sell30,000$77.71$2,331,300.00View SEC Filing Icon  
3/16/2021Sell41,173$80.64$3,320,190.72View SEC Filing Icon  
3/11/2021Sell51,367$79.03$4,059,534.01View SEC Filing Icon  
3/9/2021Sell33,480$69.43$2,324,516.40View SEC Filing Icon  
3/5/2021Sell30,000$68.03$2,040,900.00View SEC Filing Icon  
3/3/2021Sell40,000$101.76$4,070,400.00View SEC Filing Icon  
2/24/2021Sell116,443$112.07$13,049,767.01View SEC Filing Icon  
2/22/2021Sell276,250$113.78$31,431,725.00View SEC Filing Icon  
2/19/2021Sell72,367$104.83$7,586,232.61View SEC Filing Icon  
2/17/2021Sell45,000$104.82$4,716,900.00View SEC Filing Icon  
12/10/2020Sell127,515$66.94$8,535,854.10View SEC Filing Icon  
12/8/2020Sell90,748$66.33$6,019,314.84View SEC Filing Icon  
12/4/2020Sell207,239$65.50$13,574,154.50View SEC Filing Icon  
12/2/2020Sell62,607$65.74$4,115,784.18View SEC Filing Icon  
11/25/2020Sell100,364$64.35$6,458,423.40View SEC Filing Icon  
11/23/2020Sell567,017$67.63$38,347,359.718,981,664View SEC Filing Icon  
11/19/2020Sell120,051$59.02$7,085,410.02View SEC Filing Icon  
11/17/2020Sell167,202$59.80$9,998,679.60View SEC Filing Icon  
11/5/2020Sell348,747$53.70$18,727,713.90View SEC Filing Icon  
11/3/2020Sell110,000$48.80$5,368,000.00View SEC Filing Icon  
10/30/2020Sell122,000$48.55$5,923,100.00View SEC Filing Icon  
10/28/2020Sell124,711$55.33$6,900,259.63View SEC Filing Icon  
10/21/2020Sell474,453$56.63$26,868,273.39View SEC Filing Icon  
10/19/2020Sell187,446$57.42$10,763,149.32View SEC Filing Icon  
10/15/2020Sell705,304$58.45$41,225,018.80View SEC Filing Icon  
10/13/2020Sell244,698$59.32$14,515,485.36View SEC Filing Icon  
10/9/2020Sell919,793$55.10$50,680,594.30View SEC Filing Icon  
10/7/2020Sell216,061$53.86$11,637,045.46View SEC Filing Icon  
9/30/2020Sell178,366$48.41$8,634,698.06View SEC Filing Icon  
9/28/2020Sell154,840$48.38$7,491,159.20View SEC Filing Icon  
9/24/2020Sell150,000$47.58$7,137,000.00View SEC Filing Icon  
9/22/2020Sell145,525$51.40$7,479,985.00View SEC Filing Icon  
9/17/2020Sell159,923$51.67$8,263,221.41View SEC Filing Icon  
9/15/2020Sell205,965$53.97$11,115,931.05View SEC Filing Icon  
See Full Table

David E. Shaw Buying and Selling Activity at Schrödinger

This chart shows David E Shaw's buying and selling at Schrödinger by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Schrödinger Company Overview

Schrödinger logo
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Read More

Today's Range

Now: $25.68
Low: $25.64
High: $26.75

50 Day Range

MA: $27.95
Low: $24.74
High: $33.09

2 Week Range

Now: $25.68
Low: $20.76
High: $59.24

Volume

815,775 shs

Average Volume

1,180,742 shs

Market Capitalization

$1.86 billion

P/E Ratio

40.76

Dividend Yield

N/A

Beta

1.57